Literature DB >> 23716201

Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis.

Lin Ouyang1, You-Di Lv, Can Hou, Guo-Bao Wu, Zhi-Hui He.   

Abstract

There are some epidemiological studies investigating the association between interleukin-10 (IL-10) 1082A/G polymorphism and sepsis susceptibility reporting conflicting findings. Our work tried to further quantitatively assess the association of the IL-10 1082A/G polymorphism with sepsis susceptibility through a systematic review and meta-analysis. A total of eleven studies with 2,528 subjects were finally included into the meta-analysis. Pooled odds ratios (ORs) and corresponding 95 % confidence intervals (95 % CIs) were calculated with random-effects model or fixed-effects model based on the heterogeneity among the included studies. Meta-analysis of all 11 studies showed that there was an obvious association between IL-10 1082A/G polymorphism and sepsis susceptibility under the allele comparison model (G vs A) and the codominant model (GG vs AA) (for G vs A: OR = 0.83, 95 % CI 0.72-0.96, P = 0.011; for GG vs AA: OR = 0.67, 95 % CI 0.47-0.96, P = 0.029). Subgroup analysis by ethnicity showed that there was an obvious association between IL-10-1082A/G polymorphism and sepsis susceptibility in Asians under three comparison models (for G vs A: OR = 0.75, 95 % CI 0.62-0.91, P = 0.004; for GG vs AA: OR = 0.39, 95 % CI 0.21-0.73, P = 0.003; for GG vs AA/AG: OR = 0.36, 95 % CI 0.14-0.92, P = 0.032), but there was no similar association in Caucasians under all four comparison models. Our meta-analysis reveals that the IL-10-1082A/G polymorphism has an association with the susceptibility to sepsis in Asian populations. Further studies are needed to investigate the effect of IL-10-1082A/G polymorphism on sepsis susceptibility in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23716201     DOI: 10.1007/s11033-013-2520-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

1.  Activation of CXCR2 by extracellular matrix degradation product acetylated Pro-Gly-Pro has therapeutic effects against sepsis.

Authors:  Sang Doo Kim; Ha Young Lee; Jae Woong Shim; Hak Jung Kim; Young Hyun Yoo; Joon Seong Park; Suk-Hwan Baek; Brian A Zabel; Yoe-Sik Bae
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

Review 2.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

3.  Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.

Authors:  Spaska A Stanilova; Lyuba D Miteva; Zhivko T Karakolev; Chavdar S Stefanov
Journal:  Intensive Care Med       Date:  2006-01-25       Impact factor: 17.440

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Association of IL-10-1082 G/G genotype with lower mortality of acute respiratory distress syndrome in a Chinese population.

Authors:  Xiaodong Jin; Zhi Hu; Yan Kang; Chang Liu; Yongfang Zhou; Xiaodong Wu; Jin Liu; Mingxing Zhong; Chuanxing Luo; Lijing Deng; Yiyun Deng; Xiaoqi Xie; Zhongwei Zhang; Yan Zhou; Xuelian Liao
Journal:  Mol Biol Rep       Date:  2011-10-28       Impact factor: 2.316

6.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

7.  Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism.

Authors:  Bernhard M Schaaf; Florian Boehmke; Hamed Esnaashari; Ulrike Seitzer; Henning Kothe; Matthias Maass; Peter Zabel; Klaus Dalhoff
Journal:  Am J Respir Crit Care Med       Date:  2003-05-13       Impact factor: 21.405

8.  Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case-control studies.

Authors:  Feng Pan; Jing Tian; Yue-Yin Pan; Ying Zhang
Journal:  Mol Biol Rep       Date:  2012-02-05       Impact factor: 2.316

9.  Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.

Authors:  Jose Garnacho-Montero; Teresa Aldabo-Pallas; Carmen Garnacho-Montero; Aurelio Cayuela; Rocio Jiménez; Sonia Barroso; Carlos Ortiz-Leyba
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies.

Authors:  Ling Zeng; Wei Gu; Kehong Chen; Dongpo Jiang; Lianyang Zhang; Dingyuan Du; Ping Hu; Qing Liu; Suna Huang; Jianxin Jiang
Journal:  Crit Care       Date:  2009-11-26       Impact factor: 9.097

View more
  4 in total

1.  Association of susceptibility to septic shock with platelet endothelial cell adhesion molecule-1 gene Leu125Val polymorphism and serum sPECAM-1 levels in sepsis patients.

Authors:  Wei Sun; Fang-Shun Li; Yuan-Huai Zhang; Xiao-Ping Wang; Chao-Rong Wang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Association between interleukin-10 polymorphisms and sepsis: a meta-analysis.

Authors:  W Pan; A Q Zhang; C L Yue; J W Gao; L Zeng; W Gu; J X Jiang
Journal:  Epidemiol Infect       Date:  2015-01       Impact factor: 4.434

3.  Neonatal infections in Saudi Arabia: Association with cytokine gene polymorphisms.

Authors:  Gamal Allam; Adnan A Alsulaimani; Ali K Alzaharani; Amre Nasr
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

Review 4.  The Relevance of Coding Gene Polymorphysms of Cytokines and Cellular Receptors in Sepsis.

Authors:  Anca Meda Georgescu; Bianca Liana Grigorescu; Ioana Raluca Chirteș; Alexander A Vitin; Raluca Ștefania Fodor
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.